In renal cell carcinoma, Duensing had already found a longer progression-free survival in patients with no or very few MDR-1 positive tumour cells compared to the group of patients with higher MDR-1 positivity [36]. The gene discussed is ABCB1; the disease is renal cell carcinoma.